Study Group: Exubera Prescribers (US)(?)

Harold Bays, MD, FACE, FACP, is Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center (L-MARC), a metabolic clinical research facility that has conducted over 400 phase I-IV clinical trials, including studies of all marketed lipid-altering drug treatments, as well...

Dan Streja, MD, is a Clinical Professor of Medicine at the University of California, Los Angeles. He is Co-Director of the Lipid Clinic, the Cardiovascular Prevention Clinic and Diabetes Clinic, and the Divisions of Cardiology and Endocrinology at VA Medical Center of West Los Angeles. Dr. Streja has...

George Griffing, MD, is Professor of Internal Medicine at St. Louis University. Dr. Griffing's clinical expertise includes the diagnosis and treatment of diabetes. His research interests include the clinical investigation of inhaled insulin, nasal insulin and pramlintide. Dr. Griffing is a member of...

Farhad Zangeneh, MD, is an Assistant Clinical Professor of Medicine at George Washington University School of Medicine in District of Columbia. He is on the board of directors of ACCE and recently contributed to the AACE Diabetes guidelines. He is the Medical Director of Endocrine, Diabetes and Osteoporosis...

Michael Dempsey, MD, is a Private Practitioner in Rockville, Maryland. He is the Medical Director of the Johns Hopkins Diabetes Center at Suburban Hospital, where he is also the Medical Director of Diabetes Education and Endocrine Subsection Chair. He is the Vice-President of the Mid-Atlantic chapter...

Satish K. Garg is Professor of Medicine and Pediatrics at the Young Adult Clinic of the Barbara Davis Center for Diabetes of the University Of Colorado School Of Medicine in Denver, Colorado. His research interests include the early detection and treatment of renal and retinal complications of type1...